In Sherril Sego’s review of Cannabis sativa [Alternative meds update, “Marijuana,” February 2016], she failed to mention anything about the substance of cannabidiol (CBD) from the plant. This is particularly important, because this substance is the one that does not tend to produce the euphoria and other psychotic effects of the substance tetrahydrocannabinol (THC). It is thought that CBD would be much more acceptable to patients and the community at large for accepting legalizing medical marijuana, since the abuse potential tends to occur with the TCH component. Strains of this plant can be grown that are high in the CBD content, but low in the TCH component. This is a very important fact to know when discussing marijuana, especially as a medical treatment.—LINDA WENDELL, FNP, Dryden, N.Y. (210-5)
These are letters from practitioners around the country who want to share their clinical problems and successes, observations and pearls with their colleagues. We invite you to participate. If you have a clinical pearl, submit it here.